Page 126 - Read Online
P. 126

Page 14 of 16                 Pham et al. Microbiome Res Rep 2024;3:25  https://dx.doi.org/10.20517/mrr.2024.01

               capability is particularly beneficial for studying unexplored microbial communities or those from
               understudied environments.

               DECLARATIONS
               Acknowledgments
               We acknowledge Quang Tran for his contribution during the initial phase of this research.

               Authors’ contributions
               Conception and design of the method, studies, and experiments: Pham DT, Phan V
               Coding and implementation of the method, data collection, and data analysis: Pham DT


               Availability of data and materials
               Code and sample data reported in this manuscript are publicly available on GitHub (https://github.com/
               pdtrang/MetaBIDx).

               Financial support and sponsorship
               None.

               Conflicts of interest
               Both authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2024.


               REFERENCES
               1.       Voelkerding KV, Dames SA, Durtschi JD. Next-generation sequencing: from basic research to diagnostics. Clin Chem 2009;55:641-
                   58.  DOI  PubMed
               2.       National Research Council. The new science of metagenomics: revealing the secrets of our microbial planet. Washington, DC: The
                   National Academies Press; 2007.  DOI
               3.       Martín R, Miquel S, Langella P, Bermúdez-Humarán LG. The role of metagenomics in understanding the human microbiome in health
                   and disease. Virulence 2014;5:413-23.  DOI  PubMed  PMC
               4.       Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012;490:55-60.  DOI
               5.       Wang N, Zhu F, Chen L, Chen K. Proteomics, metabolomics and metagenomics for type 2 diabetes and its complications. Life Sci
                   2018;212:194-202.  DOI
               6.       Valles-Colomer M, Falony G, Darzi Y, et al. The neuroactive potential of the human gut microbiota in quality of life and depression.
                   Nat Microbiol 2019;4:623-32.  DOI
               7.       Lai J, Li A, Jiang J, et al. Metagenomic analysis reveals gut bacterial signatures for diagnosis and treatment outcome prediction in
                   bipolar depression. Psychiatry Res 2022;307:114326.  DOI  PubMed
               8.       Kishikawa T, Maeda Y, Nii T, et al. 'Comment on 'Metagenome-wide association study of gut microbiome revealed novel aetiology of
                   rheumatoid arthritis in the Japanese population' by Kishikawa et al ' by Kitamura et al. Ann Rheum Dis 2020;79:103-11.  DOI  PubMed
                                                              .
               9.       Chu Y, Sun S, Huang Y, et al. Metagenomic analysis revealed the potential role of gut microbiome in gout. NPJ Biofilms Microbiomes
                   2021;7:66.  DOI  PubMed  PMC
               10.      Eloe-Fadrosh EA, Rasko DA. The human microbiome: from symbiosis to pathogenesis. Annu Rev Med 2013;64:145-63.  DOI
                   PubMed  PMC
               11.      Teeling H, Glöckner FO. Current opportunities and challenges in microbial metagenome analysis - a bioinformatic perspective. Brief
                   Bioinform 2012;13:728-42.  DOI  PubMed  PMC
   121   122   123   124   125   126   127   128   129   130   131